Challenges in access to peptide receptor radionuclide therapy (PRRT) in developing countries – Insights from patient advocacy perspective

#4287

Introduction: As patient advocates and advocacy groups emerge as pivotal players in promoting access to healthcare, we explore their role in promoting radionuclide therapy in NETs.

Aim(s): Discussing challenges in access to Peptide Receptor Radionuclide Therapy (PRRT) in developing countries and sharing insights from eight years of patient advocacy.

Materials and methods: This is a subjective analysis of availability and access to treatment for neuroendocrine tumours in the Indian subcontinent over 8 years and experience as a physician-advocate engaged with a neuroendocrine tumour support organisation.

Conference:

Presenting Author: Dureja S

Authors: Dureja S,

Keywords: Neuroendocrine tumour, Patient Advocacy, PRRT, Theranostics, Developing countries,